• follow us on

Ayurved and Nutan Ayurvdic Research centre

  • Vata is linked to the wind, which is constantly on the move, and controls the central nervous system
  • Pitta is like the sun, a source of energy. It controls the digestive system and all biochemical processes
  • Kapha governs the balance of tissue fluid, controlling cell growth and the firmness of the body—rather as the moon governs the tides.Good health is believed to result from the three forces being in harmony—not unduly stronger or weaker than each other

Bad health is said to occur when they are out of balance. Maintaining a harmony between the different elements is the key to the ayurvedic concept. Four thousand year old references to the Nasatya are found in the now extinct, Hurrian and Hittite languages in Turkey, and in the Sanskrit language in India. Ayurveda is considered the upaveda or accessory Veda to the Atharva Veda. The four Vedas are the world's oldest literary documents in an Indo-European language.

Ayurveda's lasting influence in the non Indo-European sphere began after the rise and spread of Buddhism in the 6th century B.C.E. Buddhist monks introduced Ayurveda to China, Tibet, Korea, Mongolia and Sri Lanka, leaving a lasting legacy in their medical systems.

More recently, the German translation of an ayurvedic text that dates back to less than 1000 B.C.E., the Susruta Samhita, contributed to modern medicine the discipline of plastic surgery. Susruta mentions eight branches in ayurveda - General medicine, Surgery, ENT and Eye diseases, Toxicology, Psychiatry, Pediatrics, Gynecology, Sexology and Virility.

At N.A.R.C, we have more than 225 Ayurvedic prepar-ations which form an important part of Ayurvedic practitioner's daily practice. A complete range of Herbal products are manufactured by N.A.R.C, which are the result of years of untiring research work. The products of “Aloevera herbal concept” are organically prepared having natural characteristics of nature’s best herbs. The main content of all the products is “Aloevera Barbendisis mullar”, considered blessing to Man kind. Consumers are the prime concern of the company that’s why the products are quality oriented.

At , research begins with raw herbs chosen from traditional texts and from observations and experiences of indigenous plants. Our team of herbalists study texts, both traditional and scientific, exhaustively for relevant data. A few herbs of promising activity are short-listed. Polyherbal formulations of these short-listed herbs are made in order to provide a wider scope of pharmacological and cosmetic activity.

Very recently we have manufactured “Pancreas Activator Medicine”. Which is blessing for man kind, who are suffering from insulin dependent Diabetes Mellitus and Non insulin dependent Diabetes mellitus. We have got success in about 2000 patients suffering from Diabetes and we are planning to get it patented from WHO and hope very shortly we will be able to do so.

For more details please find attached the PDF:

Production Methodology

Produces quality aloevera herbal formulation. To monitor quality, many endangered herbs are grown by the company on its farmland as per standards of Good Manufacturing Principles (GMP) are rigorously followed in the Plant and Company prides. NARC produces quality polyherbal formulations. To monitor quality, many endangered herbs are grown by the Company on its farmland. The principles of Good Manufacturing Practices (GMP) are rigorously followed in the plant and the Company prides itself on being environment friendly. As part of the environment control system, it had installed a modern effluent treatment plant long before regulations mandated it. A high stress on quality, several quality circles and special project teams working on Total Quality Management (TQM) projects make quality a way of life inN.A.R.C.

The manufacturing plant uses automatic, high-speed punching, coating and filling machines. The tablet coating facility is one of the largest in India. The plant can produce nearly 5 billion tablets and 60 million bottles of liquids annually.

The pursuit of quality is an integral part of the fabric of our culture and comprises: consistency, care, concern, commitment, responsiveness, and, of course, technical proficiency. As a part of our proactive commitment to providing the highest-quality products possible, we periodically survey clients, the results of which ensure that we continue to meet our clients’ needs and expectations.

Quality covers two areas - Quality Assurance and Quality Control.

Pharmaceutical products are designed and developed with the following requirements -

  • GMP (Good Manufacturing Practices)
  • GLP (Good Laboratory Practice)
  • GCP (Good Clinical Practice)

GMP (Good Manufacturing Practices) for pharmaceuticals include assessment of quality, safety & efficacy:

  • Crude plant material - pharmacognosy
  • Plant preparation - analytical
  • Finished product - formulation and development
  • Stability - stability studies are conducted on all our products as per ICH (International Conference for Harmonization) guidelines to ensure quality of the product throughout its shelf-life
  • Clinical studies - Phases I, II & III, and Phase I V (post-marketing surveillance)

Safety Assessment

  • Toxicological studies - acute, subchronic, chronic, and teratogenicity

Efficacy assessment

  • Activity - pharmacological
  • Clinical studies - phases I, II, & III

Formulation of products

  • Identification (Literature surveys of ancient classical texts and scientific literature)
  • Pharmacognosy - microspical identification, macroscopical identification, maceration and cultivation
  • Preclinical pharmacology
  • Standardization - Certificate of analysis, quality assessment, purity
  • Formulation and Development - development of dosage forms, stability studies

Market Research

Recently there has been a shift in universal trend from synthetic to herbal medicine, which we can say ‘Return to Nature’. Medicinal plants have been known for millennia and are highly esteemed all over the world as a rich source of therapeutic agents for the prevention of diseases and ailments.

The demand for ayurvedic formulations is increasing both in the domestic market as well as internationally. According to some estimates, the domestic sales are growing at an annual rate of 20 per cent while the international market for medicinal plant-based products is estimated to be growing at 7 per cent per annum. However, India has a very insignificant share of the international herbal medicine market although it is one of the biggest reservoirs of plant resources.

Given the rapidly increasing demand, there is tremendous pressure on the supply base. This has reached crisis point for some species.It is reported that certain species of Medicinal plants have already become extinct through over-harvesting, and other species are endangered. Drug manufacturers make use of alternative species when the ‘first choice’ is no longer available. However, there are reports that even some of the ‘second best’ alternatives are now facing extinction.

Further, there are concerns about maintaining the quality of supplies.There are a number of potential (and some actual) responses to this demand-supply gap. These include substitution of raw material, import of medicinal plants, cultivation of plants by the corporate ayurvedic industry, cultivation of plants by farmers and enhancing production from natural habitats. In addition to these attempts to address the demand-supply crisis, there is a long-established response, which represents an unofficial, illegal response by sections of the industry, that is the use of adulterants.

There is widespread use of traditional medicines in India and this is predicted to increase.

International market

The World Health Organisation estimates that over 80 per cent of the world’s population relies on traditional plant-based medicine for their primary health care needs. During the last decade the demand for medicinal plants has grown significantly in Europe and elsewhere. The international market for medicinal plant-based products is estimated to be US$ 60 billion and is growing at the rate of 7 per cent per annum In Germany and France many herbs and herbal extracts are used as prescription drugs and their sales in the European Union were around US$ 6 billion in 1991 (and probably over US$ 20 billion now). In USA, herbal drugs are currently sold in health food stores and had a turnover of around US$ 4 billion in 1996, which was anticipated to double by the turn of the century. Nutraceuticals (nutritionally or medicinally enhanced foods with health benefits) are in great demand in the developed countries particularly USA and Japan. The nutraceutical market in USA alone is about US$ 80–250 billion, with a similar market in Europe.

Domestic market

The Indian government and non-government organizations have been collecting statistics on the Ayurvedic system in India and these data about the manpower and institutional aspects of Ayurveda have emerged:

  • Number of registered medical practitioners: 366,812
  • Number of dispensaries: 22,100
  • Number of hospitals: 2,189
  • Number of hospital beds: 33,145
  • Number of teaching institutions (undergraduate): 187
  • Number of upgraded postgraduate departments: 51
  • Number of specialties in postgraduate medical training: 16
  • Number of pharmacies manufacturing Ayurvedic medicines: 8,400

For more details please find attached the PDF:

Photo Gallery

For details of our company photographs please find below the PDF:

© Nutan Aloevera All right reserved Terms of use. Developed and managed by Metaphor IT